scispace - formally typeset
W

William E. Kraus

Researcher at Duke University

Publications -  625
Citations -  40583

William E. Kraus is an academic researcher from Duke University. The author has contributed to research in topics: Heart failure & Medicine. The author has an hindex of 93, co-authored 565 publications receiving 33692 citations. Previous affiliations of William E. Kraus include University of Texas Southwestern Medical Center & University of North Carolina at Chapel Hill.

Papers
More filters
Journal ArticleDOI

Effect of Exercise, Escitalopram, or Placebo on Anxiety in Patients With Coronary Heart Disease: The Understanding the Benefits of Exercise and Escitalopram in Anxious Patients With Coronary Heart Disease (UNWIND) Randomized Clinical Trial.

TL;DR: In this paper, a randomized clinical trial was conducted to determine whether exercise and escitalopram are better than placebo in reducing symptoms of anxiety as measured by the Hospital Anxiety and Depression-Anxiety Subscale (HADS-A) and in improving CHD risk biomarkers.
Journal ArticleDOI

The in vivo quantification of myocardial performance in rabbits: a model for evaluation of cardiac gene therapy.

TL;DR: These data validate the linear Frank-Starling relationship and the slope, MW, as a load-insensitive index of contractility in the intact rabbit and present a novel approach to the quantification of regional cardiac function in smaller animals.
Journal ArticleDOI

SLCO1B1 genetic variants, long-term low-density lipoprotein cholesterol levels and clinical events in patients following cardiac catheterization

TL;DR: Functional SLCO1B1 variants are not associated with death/MI in patients commonly treated with statins, despite higher LDL-c in carriers of the rs4149056 C allele.
Journal ArticleDOI

Short‐Term Changes in Cardiorespiratory Fitness in Response to Exercise Training and the Association with Long‐Term Cardiorespiratory Fitness Decline: The STRRIDE Reunion Study

TL;DR: Greater CRF improvement in response to short‐term training is associated with higher CRF levels 10 years later, which may identify individuals at risk for exaggerated CRF decline with aging.